Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery
SONEW
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to perform kaolin-based activated clotting time as routine monitor of heparin therapy in patients undergoing cardiac operations. In addition, the device allows the assessment of the patient's coagulation status by a glass-bead activated test. Recently, a new SONOCLOT analyzer (S2) has been developed. As part of the routine management using S1, tests are also performed on S2. Results are entered into the cardiac surgery data base of all cardiac surgery patients and analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2009
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 23, 2015
CompletedFirst Posted
Study publicly available on registry
October 28, 2015
CompletedResults Posted
Study results publicly available
April 3, 2018
CompletedMay 4, 2018
April 1, 2018
6 months
October 23, 2015
March 8, 2018
April 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Kaolin-activated Clotting Time
Routine measurements during cardiac surgery
Secondary Outcomes (1)
Glass Bead Activated Clotting Time
Routine measurements during cardiac surgery
Study Arms (1)
ACT measurements
OTHERACT measurements by SONOCLOT Analyzer during cardiac surgery
Interventions
Blood coagulation test during cardiac surgery: Measurement of activated clotting time during cardiac surgery by Sonoclot Analyzer
Eligibility Criteria
You may qualify if:
- all consecutive cardiac surgery patients
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Triemli Hospitallead
Related Publications (1)
Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008 May;106(5):1366-75. doi: 10.1213/ane.0b013e318168b367.
PMID: 18420846BACKGROUND
Results Point of Contact
- Title
- Director Clinical Trial
- Organization
- Triemli City Hospital
Study Officials
- STUDY CHAIR
Michele Genoni, MD
Triemli City Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med
Study Record Dates
First Submitted
October 23, 2015
First Posted
October 28, 2015
Study Start
July 1, 2009
Primary Completion
January 1, 2010
Study Completion
January 1, 2011
Last Updated
May 4, 2018
Results First Posted
April 3, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share